AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge

(Reuters) - A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.


from Reuters: Health News https://ift.tt/2Kjg2VU

Comentarii

Postări populare de pe acest blog

The Best Food, Drink, and Home Service Subscriptions to Give as Wedding Gifts

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

6 Easy Mother’s Day Gifts for the Mom Who Says She Doesn’t Want Anything